Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
LENSAR ( (LNSR) ) has issued an update.
On July 2, 2025, LENSAR, Inc. held a virtual special meeting where stockholders voted on proposals related to a merger agreement with Alcon Research, LLC. The merger proposal, along with a compensation proposal for executives related to the merger, was approved by the requisite vote. The adjournment proposal was deemed unnecessary as there was a quorum present and sufficient proxies to approve the merger proposal.
The most recent analyst rating on (LNSR) stock is a Buy with a $15.00 price target. To see the full list of analyst forecasts on LENSAR stock, see the LNSR Stock Forecast page.
Spark’s Take on LNSR Stock
According to Spark, TipRanks’ AI Analyst, LNSR is a Neutral.
LENSAR’s overall stock score is primarily impacted by its weak financial performance, characterized by persistent losses and financial instability. Technical analysis provides a slightly more positive outlook, but valuation metrics remain unattractive due to negative earnings. The absence of earnings call insights and corporate events does not alter the score.
To see Spark’s full report on LNSR stock, click here.
More about LENSAR
LENSAR, Inc. is a company operating in the medical technology industry, primarily focusing on the development and commercialization of femtosecond laser systems for cataract surgery.
Average Trading Volume: 146,567
Technical Sentiment Signal: Buy
Current Market Cap: $152.3M
For detailed information about LNSR stock, go to TipRanks’ Stock Analysis page.